Testosterone and Cortisol Levels in Infant Health and Development
Testosterone and Cortisol Levels in Infant Health and Development
批准号:
8647510
负责人:
JUNE I CHO
金额:
$30.5万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2019-05-31
关键词:
AffectAgeAge-MonthsAlabamaAmniotic FluidApgar ScoreBehavioralBiochemicalBiological FactorsBiological MarkersBirthBirth WeightBloodBody mass indexBrainCharacteristicsClinicCognitiveCollaborationsCollectionDataData AnalysesDevelopmentEarly identificationEducationEndocrinologistEquationExhibitsFemaleFutureGenderGestational AgeGoalsGrowthHealthHormonalHormonesHydrocortisoneImmuneInfantInfant DevelopmentInfant HealthInterventionLaboratory ResearchLanguageLanguage DevelopmentLeadLinear ModelsLongitudinal StudiesMarital StatusMeasurementMeasuresMethodsMissionModelingMothersMotorNational Institute of Child Health and Human DevelopmentNeonatalNeonatal Intensive Care UnitsNeurologicNewborn InfantOutcomeOutcome StudyPerinatalPremature InfantRaceRecruitment ActivityResearchResearch DesignRiskRoleSalivaScheduleSex CharacteristicsSocializationSourceSystemTestosteroneTimeUmbilical Cord BloodUniversitiesUpdateVery Low Birth Weight InfantVideotapeVisitWomanbasecomparativedesignearly childhoodexperiencefetal bloodfollow-upinfancyinfant outcomeinfant temperamentinsightmaleneonateprematurepsychologicpublic health relevancetheoriestherapy development
中文摘要
项目摘要/摘要
确定负面健康结局的早期标记物是维持最佳婴儿的关键
发展和制定成功的健康干预措施,特别是针对极低出生体重(VLBW,
出生体重低于1,500克)早产男婴比
女婴。
一般性别差异理论和极端男性大脑理论以及我们的初步研究
提示婴儿的睾丸激素和皮质醇水平呈正相关,呈负相关。
与婴幼儿早期的健康结果和1至3岁的发育结果有关。
我们计划确认睾丸激素而不是皮质醇是并发症的更可靠的标记/预测因子
影响婴儿健康结局、母婴互动和婴儿认知/运动/语言
发育结果;男婴对睾酮水平的敏感性高于女婴
这些结果证明了婴儿的健康状况。
本研究采用纵向对比研究设计,旨在描述性别差异。
通过睾酮和皮质醇水平测量(1)新生儿和婴儿的健康结果,(2)质量
母婴互动;(3)母婴校正后的婴儿认知/运动/语言发展。
心理状态、婴儿气质和母亲的特征。190名母亲--VLBW
早产儿配对将从加州大学新生儿重症监护病房(NICU)招募
阿拉巴马州伯明翰附属妇婴中心。这对夫妇的人口统计和健康数据将
在NICU收集,并在新生儿随访诊所更新,那里的婴儿被安排在三个月
出院后随访(6、12和24个月矫正的早产儿年龄)。在此期间
探视,母婴互动将被录像15分钟,婴儿认知/运动/语言
将使用适合年龄的测量方法收集发育结果。并发与重复
婴儿和母亲的睾酮和皮质醇水平的测量将通过
婴儿期和儿童期早期(出生时,月经后40周,校正年龄为6、12和24个月)。
首先将进行探索性数据分析,以深入了解收集到的数据。广义线性
模型将用于建模具有一次采集的独立数据,而广义估计
方程和广义线性混合效应模型是建立相关模型的标准方法
纵向数据。
英文摘要
Project Summary/Abstract
Identification of early markers for negative health outcomes is critical to maintaining optimal infant
development and for developing successful health interventions, particularly for very low birth weight (VLBW,
birth weight less than 1,500 g) preterm male infants who are more prone to health-related problems than
female infants.
General gender-difference theories and the extreme male brain theories, as well as our preliminary studies
suggest that testosterone and cortisol levels are positively related to each other in infants and are negatively
associated with infant health outcomes in early infancy and with developmental outcomes between ages 1 to 3.
We plan to confirm that testosterone rather than cortisol is a more reliable marker/predictor of complications
affecting infants' health outcomes, mother-infant interactions, and infant cognitive/motor/ language
developmental outcomes; and that male infants exhibit a higher sensitivity to testosterone levels than female
infants as evidenced by these outcomes.
This study involves a comparative and longitudinal research design aimed at describing gender differences
measured by testosterone and cortisol levels with (1) health outcomes of neonates and infants, (2) quality of
mother-infant interactions, and (3) infant cognitive/motor/language development after adjusting for maternal
psychological state, infant temperament, and characteristics of mothers. One hundred ninety mother-VLBW
preterm infant pairs will be recruited from the neonatal intensive care unit (NICU) at the University of
Alabama at Birmingham affiliated Women and Infants Center. Demographic and health data of the pairs will
be collected at the NICU and updated at the newborn follow-up clinic where the infants are scheduled for three
follow-up visits (at 6, 12, and 24 months corrected age for prematurity) following discharge. During these
visits, mother-infant interactions will be videotaped for 15 min and infant cognitive/motor/language
developmental outcomes will be collected using age-appropriate measurements. Concurrent and repeated
measurement of testosterone and cortisol levels both in infants and in mothers will be conducted through
infancy and early childhood (at birth, 40 weeks postmenstrual age and 6 , 12 , and 24 months corrected age).
Exploratory data analysis will first be performed to gain insight into the collected data. Generalized linear
models will be used to model independent data with one time collection while the generalized estimating
equation and the generalized linear mixed-effects models are standard approaches for modeling correlated
longitudinal data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Testosterone and Cortisol Levels in Infant Health and Development
-
批准号:9113358
-
项目类别:
-
资助金额:$33.89万
-
财政年份:2014
-
负责人:JUNE I CHO
-
依托单位:
Testosterone and Cortisol Levels in Infant Health and Development
-
批准号:9143252
-
项目类别:
-
资助金额:$31.52万
-
财政年份:2014
-
负责人:JUNE I CHO
-
依托单位:
Perinatal Testosterone in Infant Health, Mother-Infant Interaction and Developmen
-
批准号:8103197
-
项目类别:
-
资助金额:$17.58万
-
财政年份:2010
-
负责人:JUNE I CHO
-
依托单位:
Perinatal Testosterone in Infant Health, Mother-Infant Interaction and Developmen
-
批准号:7963591
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2010
-
负责人:JUNE I CHO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: